Mark Kubik

Mark Kubik Email and Phone Number

Head of Business Development - Oncology @ Akari Therapeutics, Plc
Longmont, CO, US
Mark Kubik's Location
Longmont, Colorado, United States, United States
Mark Kubik's Contact Details
About Mark Kubik

Biopharmaceutical Business Development Leadership

Mark Kubik's Current Company Details
Akari Therapeutics, Plc

Akari Therapeutics, Plc

View
Head of Business Development - Oncology
Longmont, CO, US
Mark Kubik Work Experience Details
  • Akari Therapeutics, Plc
    Head Of Business Development - Oncology
    Akari Therapeutics, Plc
    Longmont, Co, Us
  • Athira Pharma
    Business Development
    Athira Pharma Oct 2024 - Present
    Bothell, Washington, Us
  • Stealth Mode Biotech
    Head Of Business Development
    Stealth Mode Biotech Jan 2024 - Nov 2024
    Sevenoaks, Gb
  • I-Mab Biopharma
    Svp, U.S. & E.U. Business Development
    I-Mab Biopharma Jun 2022 - Dec 2023
    Rockville, Maryland, Us
  • I-Mab Biopharma
    Svp, U.S. & E.U. Business Development
    I-Mab Biopharma Jun 2022 - Dec 2023
    Rockville, Maryland, Us
  • Genor Biopharma Co., Ltd.
    Chief Business Officer
    Genor Biopharma Co., Ltd. Aug 2021 - May 2022
  • Actinium Pharmaceuticals, Inc.
    Chief Business Officer (Cbo)
    Actinium Pharmaceuticals, Inc. Feb 2021 - Aug 2021
    New York, Ny, Us
  • Oncoimmune, Inc.
    Chief Business Officer
    Oncoimmune, Inc. Sep 2020 - Jan 2021
  • Avantgen, Inc.
    Chief Business Officer (Cbo)
    Avantgen, Inc. Nov 2019 - Sep 2020
    San Diego, California, Us
  • Invenra
    Chief Business Officer
    Invenra Aug 2018 - Aug 2019
    Led the Invenra Business Development TeamDeveloped and Managed new business opportunitiesLed Alliance and Portfolio ManagementOversaw pipeline of immuno-oncology bispecific (B-Body(TM) and SNIPER(TM)) antibodiesOversaw Strategic Partnerships
  • I2 Pharmaceuticals
    Chief Business Officer
    I2 Pharmaceuticals Feb 2017 - Jul 2018
    Driven to Cure Cancer !Building an innovative biopharmaceutical business around transformative technologies and products across all major therapeutic and diagnostic modalities:1) third generation aptamer technology;2) small molecule discovery; and3) monoclonal antibody (mAb) and empowered mAbs
  • Invenra, Inc.
    Senior Vice President, Business Development
    Invenra, Inc. Feb 2016 - Oct 2016
    Madison, Wisconsin, Us
  • Invenra, Inc.
    Vice President, Business Development
    Invenra, Inc. Jan 2015 - Feb 2016
    Madison, Wisconsin, Us
    Invenra is a private company focused on antibody discovery using next generation technologies for mAb and empowered mAb therapeutics.As a senior member of the Executive Team, my role was to lead our Business Development function, including:Technology Out-Licensing / PartneringProduct Out-Licensing / PartneringAlliance ManagementProduct and Technology In-Licensing
  • Macrogenics, Inc.
    Senior Director, Business Development
    Macrogenics, Inc. 2011 - 2015
    Rockville, Md, Us
    Technology Out-Licensing & PartneringProduct Out-Licensing & PartneringProduct & Technology In-Licensing & PartneringAlliance ManagementMergers & Acquisitions
  • Dendreon
    Business Development Consultant
    Dendreon 2010 - 2011
    Seal Beach , Ca, Us
    Full Time Business Development Consultant
  • Seattle Genetics
    Director, Business Development
    Seattle Genetics Mar 2007 - 2010
    Bothell, Washington, Us
    Management - Head of Business DevelopmentProduct Out-Licensing / PartneringTechnology Out-LicensingProduct and Technology In-LicensingMergers & AcquisitionsAlliance Management
  • Xoma
    Associate Director, Business Development
    Xoma Aug 2005 - Mar 2007
    Emeryville, California, Us
    Technology Out-LicensingCollaboration Management
  • Protein Design Labs (Pdl Biopharma)
    Senior Manager, Business Development
    Protein Design Labs (Pdl Biopharma) 2003 - Aug 2005
    Us
    Product Out-Licensing / PartneringTechnology and Patent Out-LicensingMergers & Acquisitions
  • Abgenix
    Business Development Manager
    Abgenix 2001 - 2002
    Us
    Target and Technology Out-Licensing / PartneringTarget and Technology In-Licensing / AcquisitionCollaboration Management
  • Abgenix
    Business Development Associate
    Abgenix 1999 - 2001
    Us
    Market ForecastsCompetitive Landscape AnalysesComprehensive Financial Model BuildingDue Diligence Team LeaderCommercial and Strategic AnalysesEstablished Revenue Recognition Models w/ FinanceManaged Trade Shows and Conferences
  • Genomica Corporation
    Sales Support Scientist
    Genomica Corporation 1998 - 1999
    Developed Marketing Plans for Bioinformatic SoftwareInitiated, Developed, and Managed Client ContactsMarket Research and Competitive AnalysesPublished Papers, Demonstrated Software Products WW
  • Nexstar Pharmaceuticals
    Technology Development Specialist
    Nexstar Pharmaceuticals 1996 - 1997
    Financial Valuation, Competitive Intelligence and Intellectual Property AnalysesInitiated, Developed and Managed Partnering Contacts
  • Nexstar Pharmaceuticals
    Research Associate Iii
    Nexstar Pharmaceuticals 1992 - 1996
    Performed SELEX (Systematic Evolution of Ligands by Exponential Enrichment) experiments to find aptamers; against therapeutically relevant target molecules

Mark Kubik Skills

Biotechnology Biopharmaceuticals Life Sciences Drug Development Pharmaceutical Industry Lifesciences Drug Discovery Technology Transfer Due Diligence Business Development Oncology Commercialization Competitive Intelligence Immunology Patents Strategic Alliances Out Licensing Clinical Development Gmp R&d Market Research Monoclonal Antibodies Competitive Analysis Mergers And Acquisitions Intellectual Property Cell Culture Vaccines

Mark Kubik Education Details

  • University Of Colorado Boulder - Leeds School Of Business
    University Of Colorado Boulder - Leeds School Of Business
    Finance
  • University Of Colorado Boulder
    University Of Colorado Boulder
    Cellular And Developmental Biology (Mcdb)
  • Stanford University Graduate School Of Business
    Stanford University Graduate School Of Business
    Negotiation And Influence Strategies
  • Center For Creative Leadership (Ccl)
    Center For Creative Leadership (Ccl)
    Leadership

Frequently Asked Questions about Mark Kubik

What company does Mark Kubik work for?

Mark Kubik works for Akari Therapeutics, Plc

What is Mark Kubik's role at the current company?

Mark Kubik's current role is Head of Business Development - Oncology.

What is Mark Kubik's email address?

Mark Kubik's email address is mk****@****hoo.com

What is Mark Kubik's direct phone number?

Mark Kubik's direct phone number is +154096*****

What schools did Mark Kubik attend?

Mark Kubik attended University Of Colorado Boulder - Leeds School Of Business, University Of Colorado Boulder, Stanford University Graduate School Of Business, Center For Creative Leadership (Ccl).

What skills is Mark Kubik known for?

Mark Kubik has skills like Biotechnology, Biopharmaceuticals, Life Sciences, Drug Development, Pharmaceutical Industry, Lifesciences, Drug Discovery, Technology Transfer, Due Diligence, Business Development, Oncology, Commercialization.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.